Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s share price reached a new 52-week low during trading on Monday . The stock traded as low as C$0.00 and last traded at C$7.11, with a volume of 115417 shares changing hands. The stock had previously closed at C$7.37.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on ACB shares. Atb Cap Markets raised Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. ATB Capital cut their price objective on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Finally, TD Securities raised Aurora Cannabis to a "strong-buy" rating in a report on Thursday, December 12th.
Read Our Latest Report on Aurora Cannabis
Aurora Cannabis Price Performance
The company has a fifty day simple moving average of C$6.87 and a two-hundred day simple moving average of C$7.12. The company has a current ratio of 3.42, a quick ratio of 2.48 and a debt-to-equity ratio of 18.72. The stock has a market capitalization of C$374.75 million, a P/E ratio of -8.46 and a beta of 2.71.
Insider Activity at Aurora Cannabis
In other news, Senior Officer Andre Jerome sold 13,390 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of C$9.30, for a total value of C$124,524.32.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Read More
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
